Literature DB >> 9448613

Surgical strategy for the management of hilar bile duct cancer.

Y Parc1, P Frileux, P Balladur, E Delva, L Hannoun, R Parc.   

Abstract

BACKGROUND: Since the first attempts at resection of Klatskin tumours, an increasingly aggressive surgical treatment has been proposed. Results obtained after examination of the specimen have shown that a significant proportion of resections were palliative. Curative resection appears to be difficult to perform selectively.
METHODS: This retrospective study evaluates the results of a surgically-oriented management of hilar bile duct cancers. Thirty-nine patients were operated on in the period 1982-1994. Eighteen resections were carried out, requiring liver resection in 13 cases. Pathology of the specimen showed that the resection had been curative in 14 cases. The remaining 21 patients had surgical palliation, i.e. bypass and/or stenting.
RESULTS: In the resection group, there was no death but four patients suffered severe complications. The 1- and 5-year survival rates were 67 and 47 per cent respectively, with a median survival of 26 months. In the palliation group, the mortality rate was 14 per cent and median survival was 7 months.
CONCLUSION: In the absence of evident contraindications, surgical exploration is worthwhile as it allows detection of the cases where curative resection is possible. Curative resection often requires a major hepatectomy, but mortality and morbidity may be kept low, and it offers a real hope of cure.

Entities:  

Mesh:

Year:  1997        PMID: 9448613

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  4 in total

1.  Palliative decompression of obstructive hilar malignancies utilizing an extrahilar biliary approach.

Authors:  S Yilmaz; V Kirimlioglu; D A Katz; M Caglikulekci; M Yilmaz
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

2.  Peripheral hepatojejunostomy as palliative treatment for irresectable malignant tumors of the liver hilum.

Authors:  H J Schlitt; A Weimann; J Klempnauer; K J Oldhafer; B Nashan; R Raab; R Pichlmayr
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

3.  Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis.

Authors:  Harald Puhalla; Thomas Gruenberger; Herwig Pokorny; Thomas Soliman; Fritz Wrba; Ulrike Sponer; Thomas Winkler; Meinhard Ploner; Markus Raderer; Rudolf Steininger; Ferdinand Mühlbacher; Friedrich Laengle
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

4.  Radiofrequency ablation as a treatment for hilar cholangiocarcinoma.

Authors:  Wei-Jun Fan; Pei-Hong Wu; Liang Zhang; Jin-Hua Huang; Fu-Jun Zhang; Yang-Kui Gu; Ming Zhao; Xiang-Long Huang; Chang-Yu Guo
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.